Improvements made to the subject matter of principal patent no. 8703715 for: "Process for obtaining N-[2- hydroxy-5-[1-hydroxy-2-[[2-[4-methoxyphenyl]-1- methylethyl]amino]ethyl]phenyl] formamide".
ES2009246A6
Imidazolyl quinoxaline deriv. prepn.
ES2005492A6
N-hydroxyphenyl formamide deriv. prepn.
ES8707127A1
Modification of ion exchange resins of basic type
ES8707228A1
Di:hydro imidazole deriv. prepn.
ES8800144A1
N-acetyl cysteine thioester prepn.
ES8606278A1
Tetra:hydro-bi:pyridine deriv. prepn.
ES8606349A1
Antiviral amino-purine derivs. prepn.
ES8606350A1
Prepn. of vitamin-B4 deriv.
ES8605487A1
Distn. stations for aromatic plants
ES8606309A1
Prepn. of guanidine deriv. for gastrointestinal infections
ES8604572A1
Imidazoline derivs.
ES8604493A1
Ester deriv. of di:methylamino-acetic acid
ES8604538A1
Guanidine deriv. of thiazole
ES8605461A1
Optically-active glyceryl-aryl ether(s) prepn.
ES8604114A1
2-Anilino-benzoic acid derivs. prepn.
ES8604108A1
Amino-hydroxybenzoic acid derivs. for treatment of ulcerous colitis
ES8603387A1
Glycollic acid ester
ES8603381A1
Glycine ester of metho:carbamol
ES8601113A1
Preparation of an ester for psychosomatic disorders, etc.
